Last reviewed · How we verify
secbutabarbital
secbutabarbital is a drug. It is currently in unknown development for Dysuria, Insomnia, Severe anxiety (panic).
Secbutabarbital is a small molecule barbiturate medication used as a prescription sleep aid and anxiety medication. It has a fast onset of effects and short duration of action, making it useful for treating severe insomnia, relieving general anxiety, and relieving anxiety before surgical procedures.
At a glance
| Generic name | secbutabarbital |
|---|---|
| Target | GABA-A receptor alpha-1/beta-2/gamma-2 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Approved indications
- Dysuria
- Insomnia
- Severe anxiety (panic)
- Urinary Tract Irritation
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- secbutabarbital CI brief — competitive landscape report
- secbutabarbital updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about secbutabarbital
What is secbutabarbital?
secbutabarbital is a pharmaceutical drug, indicated for Dysuria, Insomnia, Severe anxiety (panic).
What is secbutabarbital used for?
secbutabarbital is indicated for Dysuria, Insomnia, Severe anxiety (panic), Urinary Tract Irritation.
What development phase is secbutabarbital in?
secbutabarbital is in unknown.
What does secbutabarbital target?
secbutabarbital targets GABA-A receptor alpha-1/beta-2/gamma-2.
Related
- Target: All drugs targeting GABA-A receptor alpha-1/beta-2/gamma-2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Dysuria
- Indication: Drugs for Insomnia
- Indication: Drugs for Severe anxiety (panic)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing